Answers are grounded in this paper and cite their sources.
Structural analysis reveals that DAF binds to CVB3 by bridging the viral canyon and blocking the CAR binding site, indicating a distinct evolutionary binding mechanism compared to echoviruses.
Many entero-, parecho-, and rhinoviruses use immunoglobulin (Ig)-like receptors that bind into the viral canyon and are required to initiate viral uncoating during infection. However, some of these viruses use an alternative or additional receptor that binds outside the canyon. Both the coxsackievirus-adenovirus receptor (CAR), an Ig-like molecule that binds into the viral canyon, and decay-accelerating factor (DAF) have been identified as cellular receptors for coxsackievirus B3 (CVB3). A cryoelectron microscopy reconstruction of a variant of CVB3 complexed with DAF shows full occupancy of the DAF receptor in each of 60 binding sites. The DAF molecule bridges the canyon, blocking the CAR binding site and causing the two receptors to compete with one another. The binding site of DAF on CVB3 differs from the binding site of DAF on the surface of echoviruses, suggesting independent evolutionary processes.
No takes yet. Share an insight, caveat, or question.
Hafenstein et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: